A detailed history of Banco Santander, S.A. transactions in Abbott Laboratories stock. As of the latest transaction made, Banco Santander, S.A. holds 12,023 shares of ABT stock, worth $1.36 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,023
Previous 12,971 7.31%
Holding current value
$1.36 Million
Previous $1.47 Million 15.26%
% of portfolio
0.02%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$100.73 - $112.44 $95,492 - $106,593
-948 Reduced 7.31%
12,023 $1.25 Million
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $14.3 Million - $15.8 Million
-130,926 Reduced 90.99%
12,971 $1.47 Million
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $3.73 Million - $4.56 Million
-41,317 Reduced 22.31%
143,897 $15.8 Million
Q3 2023

Nov 08, 2023

BUY
$95.53 - $114.62 $1.96 Million - $2.35 Million
20,542 Added 12.47%
185,214 $17.9 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $10.6 Million - $11.8 Million
105,138 Added 176.6%
164,672 $18 Million
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $1.43 Million - $1.68 Million
-14,767 Reduced 19.87%
59,534 $6.03 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $1.06 Million - $1.25 Million
11,202 Added 17.75%
74,301 $8.16 Million
Q3 2022

Nov 08, 2022

SELL
$96.76 - $112.03 $2.23 Million - $2.58 Million
-23,032 Reduced 26.74%
63,099 $6.11 Million
Q2 2022

Jul 28, 2022

SELL
$102.07 - $123.37 $11.9 Million - $14.4 Million
-116,841 Reduced 57.57%
86,131 $9.36 Million
Q1 2022

May 09, 2022

BUY
$114.02 - $139.04 $7.52 Million - $9.17 Million
65,978 Added 48.16%
202,972 $24 Million
Q4 2021

Feb 09, 2022

BUY
$115.53 - $141.46 $3.96 Million - $4.85 Million
34,303 Added 33.4%
136,994 $19.3 Million
Q3 2021

Nov 08, 2021

BUY
$116.66 - $129.06 $11.2 Million - $12.3 Million
95,596 Added 1347.37%
102,691 $12.1 Million
Q2 2021

Jul 29, 2021

SELL
$105.79 - $124.53 $817,545 - $962,367
-7,728 Reduced 52.14%
7,095 $822,000
Q1 2021

May 10, 2021

BUY
$108.84 - $128.23 $950,064 - $1.12 Million
8,729 Added 143.24%
14,823 $1.78 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $84,210 - $91,764
-802 Reduced 11.63%
6,094 $667,000
Q3 2020

Nov 09, 2020

SELL
$91.64 - $111.29 $975,232 - $1.18 Million
-10,642 Reduced 60.68%
6,896 $751,000
Q2 2020

Aug 05, 2020

BUY
$76.57 - $98.0 $774,811 - $991,662
10,119 Added 136.39%
17,538 $1.6 Million
Q1 2020

May 11, 2020

SELL
$62.82 - $91.86 $11,684 - $17,085
-186 Reduced 2.45%
7,419 $585,000
Q4 2019

Feb 07, 2020

SELL
$78.51 - $87.4 $10.4 Million - $11.6 Million
-132,190 Reduced 94.56%
7,605 $660,000
Q3 2019

Nov 06, 2019

BUY
$81.84 - $88.74 $10.8 Million - $11.7 Million
132,014 Added 1696.62%
139,795 $11.7 Million
Q2 2019

Aug 07, 2019

SELL
$72.88 - $85.0 $22,082 - $25,755
-303 Reduced 3.75%
7,781 $655,000
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $224,638 - $247,933
-3,902 Reduced 32.55%
8,084 $494,000
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $674,452 - $762,549
11,986 New
11,986 $718,000
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $586,829 - $628,262
-10,932 Closed
0 $0
Q3 2017

Nov 13, 2017

SELL
$48.06 - $53.64 $105,732 - $118,008
-2,200 Reduced 16.75%
10,932 $584,000
Q2 2017

Aug 11, 2017

BUY
N/A
13,132
13,132 $561,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Banco Santander, S.A. Portfolio

Follow Banco Santander, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.